These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 17255798)

  • 1. Do chronic inhaled steroids alone or in combination with a bronchodilator prolong life in chronic obstructive pulmonary disease patients?
    Sin DD; Man SF
    Curr Opin Pulm Med; 2007 Mar; 13(2):90-7. PubMed ID: 17255798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL; Baker EL; Coleman CI
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone.
    Mapel DW; Nelson LS; Lydick E; Soriano J; Yood MU; Davis KJ
    COPD; 2007 Jun; 4(2):127-34. PubMed ID: 17530506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical course of chronic obstructive pulmonary disease: review of therapeutic interventions.
    Anzueto A
    Am J Med; 2006 Oct; 119(10 Suppl 1):46-53. PubMed ID: 16996899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combined inhaled corticosteroid and long-acting beta-2-agonist in one inhaler in the treatment of chronic obstructive pulmonary disease].
    Pedersen ST
    Ugeskr Laeger; 2005 Jun; 167(23):2504-6. PubMed ID: 16008004
    [No Abstract]   [Full Text] [Related]  

  • 6. Optimizing treatment of chronic obstructive pulmonary disease: an assessment of current therapies.
    Wise RA; Tashkin DP
    Am J Med; 2007 Aug; 120(8 Suppl 1):S4-13. PubMed ID: 17678942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease.
    Sin DD; Wu L; Anderson JA; Anthonisen NR; Buist AS; Burge PS; Calverley PM; Connett JE; Lindmark B; Pauwels RA; Postma DS; Soriano JB; Szafranski W; Vestbo J
    Thorax; 2005 Dec; 60(12):992-7. PubMed ID: 16227327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases.
    Sin DD; Man SF
    Eur J Pharmacol; 2006 Mar; 533(1-3):28-35. PubMed ID: 16457807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of chronic obstructive pulmonary disease: moving beyond the asthma algorithm.
    Gordon E; Lazarus SC
    J Allergy Clin Immunol; 2009 Nov; 124(5):873-80; quiz 881-2. PubMed ID: 19895979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic evaluation of treating chronic obstructive pulmonary disease with inhaled corticosteroids and long-acting beta2-agonists in a health maintenance organization.
    Gagnon YM; Levy AR; Spencer MD; Hurley JS; Frost FJ; Mapel DW; Briggs AH
    Respir Med; 2005 Dec; 99(12):1534-45. PubMed ID: 16291076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM; White CM; Coleman CI
    Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential side effects in patients treated with inhaled corticosteroids and long-acting beta2-agonists.
    Korsgaard J; Ledet M
    Respir Med; 2009 Apr; 103(4):566-73. PubMed ID: 19136239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pneumology. Inhaled corticosteroids in COPD: more and interesting data!].
    Rochat T
    Rev Med Suisse; 2008 Jan; 4(140):155-7. PubMed ID: 18309880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy for mortality reduction in chronic obstructive pulmonary disease.
    Sin DD; Man SF
    Proc Am Thorac Soc; 2006 Sep; 3(7):624-9. PubMed ID: 16963545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can inhaled fluticasone alone or in combination with salmeterol reduce systemic inflammation in chronic obstructive pulmonary disease? Study protocol for a randomized controlled trial [NCT00120978].
    Sin DD; Man SF; Marciniuk DD; Ford G; FitzGerald M; Wong E; York E; Mainra RR; Ramesh W; Melenka LS; Wilde E; Cowie RL; Williams D; Rousseau R;
    BMC Pulm Med; 2006 Feb; 6():3. PubMed ID: 16460562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhaled corticosteroids in patients with COPD: maintain current guidelines].
    Heijdra YF
    Ned Tijdschr Geneeskd; 2007 Oct; 151(40):2195-7. PubMed ID: 17969568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid therapy in chronic obstructive pulmonary disease.
    OBrien A; Ward NS
    Med Health R I; 2002 Feb; 85(2):52-5. PubMed ID: 11881166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Friend or foe: combination therapy with inhaled corticosteroids and long-acting beta2-agonists in chronic obstructive pulmonary disease (COPD)].
    Gillissen A; Gessner C; Hoheisel G; Juergens U
    Pneumologie; 2008 Jul; 62(7):430-7. PubMed ID: 18398787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adding long-acting beta-agonists to inhaled corticosteroids after discharge from the emergency department for acute asthma: a randomized controlled trial.
    Rowe BH; Wong E; Blitz S; Diner B; Mackey D; Ross S; Senthilselvan A
    Acad Emerg Med; 2007 Oct; 14(10):833-40. PubMed ID: 17898245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Do inhaled corticosteroids reduce mortality in chronic obstructive pulmonary disease?].
    Bridevaux PO; Leuenberger P
    Rev Med Suisse; 2005 Nov; 1(41):2673-4, 2677-9. PubMed ID: 16355882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.